Magellan Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 02-07-2024
- Paid Up Capital ₹ 0.10 M
as on 02-07-2024
- Company Age 10 Year, 11 Months
- Last Filing with ROC 31 Mar 2022
- Revenue -100.00%
(FY 2020)
- Profit 28.91%
(FY 2020)
- Ebitda 60.46%
(FY 2020)
- Net Worth -14.76%
(FY 2020)
- Total Assets -54.72%
(FY 2020)
About Magellan Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Abhiram Dukkipati, Nageswararao Dukkipati, and Laxmi Wagle serve as directors at the Company.
- CIN/LLPIN
U73100TG2013PTC090647
- Company No.
090647
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Oct 2013
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
K.V.Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Magellan Life Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhiram Dukkipati  | Director | 22-Oct-2013 | Current |
| Nageswararao Dukkipati | Director | 22-Oct-2013 | Current |
| Laxmi Wagle | Director | 08-Jan-2018 | Current |
Financial Performance and Corporate Structure Insights of Magellan Life Sciences.
Magellan Life Sciences Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 100% decrease. The company also saw a substantial improvement in profitability, with a 28.91% increase in profit. The company's net worth observed a substantial decline by a decrease of 14.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Magellan Life Sciences?
In 2019, Magellan Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Drive Lozics Private Limited
Active
12 years 11 months Abhiram Dukkipati and Nageswararao Dukkipati are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Magellan Life Sciences?
Unlock and access historical data on people associated with Magellan Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Magellan Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Magellan Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
